SEC Form 4 · accession 0001213900-26-072928
Parabilis Medicines, Inc. · PBLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Soleus Capital, LLC
10% Owner
Soleus Capital Management, L.P.
10% Owner
Soleus Capital Master Fund, L.P.
10% Owner
Soleus Capital Group, LLC
10% Owner
Guy Levy
10% Owner
Soleus Private Equity GP III, LLC
10% Owner
Soleus Private Equity Fund III, L.P.
10% Owner
Soleus GP, LLC
10% Owner
Soleus PE GP III, LLC
10% Owner
Period of report
Jun 11, 2026
Accepted (ET)
Jun 29, 2026 · 10:41 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001657677
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per shareF4 | Jun 11, 2026 | P | 375,000 | $20.00 | A | 1,027,000 | I | See footnote |
| Common Stock, par value $0.0001 per shareF2,F3 | Jun 11, 2026 | P | 125,000 | $20.00 | A | 652,000 | I | See footnote |
| Common Stock, par value $0.0001 per shareF2,F3 | Jun 11, 2026 | C | 527,070 | $9.48 | A | 527,070 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series F Preferred StockF2,F3,F1 | $9.48 | Jun 11, 2026 | C | 527,070 | D | — | — | Common Stock | 527,070 | 0 | I |
Explanation of responses
- F1The Series F Preferred Stock automatically converted into shares of the common stock of the issuer immediately prior to the closing of the issuer's initial public offering without payment of consideration and had no expiration date.
- F2The reportable securities are owned directly by Soleus Private Equity Fund III, L.P. ("Soleus PE"). Soleus Private Equity GP III, LLC ("Soleus PE GP") is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, Soleus Capital Management, L.P. ("SCM") is the investment manager for Soleus PE, and Soleus GP, LLC ("Soleus GP") is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC and Soleus GP.
- F3Each of Mr. Levy, Soleus PE GP III, LLC, Soleus PE GP, SCM and Soleus GP disclaims beneficial ownership of the securities held by Soleus PE other than for the purpose of determining their obligations under Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such securities for any other purpose, except to the extent of their respective pecuniary interests therein.
- F4The reportable securities are owned directly by Soleus Capital Master Fund, L.P. ("MF"). Soleus Capital LLC is the sole general partner of MF, Soleus Capital Group, LLC ("SCG") is the sole managing member of Soleus Capital, LLC, SCM is the investment manager of MF, and Soleus GP is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and Soleus GP. Each of Mr. Levy, SCG, Soleus Capital LLC, SCM and Soleus GP disclaims beneficial ownership of the securities held by MF other than for the purpose of determining their obligations under Section 16 of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such securities for any other purpose, except to the extent of their respective pecuniary interests therein.